Affimed (AFMD)
(Delayed Data from NSDQ)
$3.40 USD
-0.29 (-7.86%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $3.41 +0.01 (0.29%) 7:14 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Earnings News For AFMD
-
Affimed N.V.: Q2 Earnings Snapshot
-
Affimed Reports Second Quarter 2024 Financial Results & Business Update
-
Affimed (AFMD) to Report Q2 Earnings: What's in the Cards?
-
Affimed N.V.: Q1 Earnings Snapshot
-
Affimed Reports First Quarter 2024 Financial Results & Business Update
-
Affimed N.V.: Q3 Earnings Snapshot
-
Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
-
Affimed N.V. (AFMD) Reports Q2 Loss, Misses Revenue Estimates
-
Affimed N.V.: Q2 Earnings Snapshot
-
Affimed Reports Second Quarter 2023 Financial Results and Highlights Operational Progress
-
Affimed N.V. (AFMD) Reports Q1 Loss, Lags Revenue Estimates
-
Affimed N.V.: Q1 Earnings Snapshot
-
Affimed Reports First Quarter 2023 Financial Results and Highlights Operational Progress
-
Affimed N.V. (AFMD) Reports Q4 Loss, Tops Revenue Estimates
-
Affimed N.V. (AFMD) Reports Q3 Loss, Tops Revenue Estimates
-
Affimed N.V.: Q3 Earnings Snapshot
-
Affimed Reports Third Quarter 2022 Financial Results and Highlights Recent Clinical and Corporate Progress
-
Analysts Estimate Affimed N.V. (AFMD) to Report a Decline in Earnings: What to Look Out for
-
Affimed N.V. (AFMD) Reports Q2 Loss, Lags Revenue Estimates
-
Affimed N.V.: Q2 Earnings Snapshot
-
Affimed N.V. (AFMD) Reports Q1 Loss, Misses Revenue Estimates
-
Affimed N.V. (AFMD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Affimed N.V. (AFMD) Reports Q3 Loss, Lags Revenue Estimates
-
Affimed N.V. (AFMD) Expected to Beat Earnings Estimates: Should You Buy?
-
Affimed N.V. (AFMD) Reports Q2 Loss, Lags Revenue Estimates